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SUMMARY
Despite treatment with praziquantel (PZQ) at 40mg/kg in food, several chimpanzees on Ngamba Island Chimpanzee
Sanctuary (NICS) continue to excrete eggs of Schistosoma mansoni. To monitor disease, 8 animals were closely examined
under anaesthesia in March 2011 with portable ultrasonography and by rectal snip biopsy. Schistosome genetic diversity
had been previously assayed within 4 of these chimpanzees, ﬁnding extensive diversity with 27DNAbarcodes encountered,
although nonewas common to all animals. Calciﬁed schistosome eggs were found in the rectal snips from 5 chimpanzees and
liver ﬁbrosis was clearly documented, indicative of progressive disease in 6 animals, the latter being surprisingly advanced in
a younger chimpanzee. All 8 animals were treated under anaesthesia by oral gavage with PZQ at 60mg/kg dosing that was
well tolerated. These animals were again re-examined in June 2012 using stool and urine sampling. Only 1 chimpanzee
appeared to be free from infection and active egg excretion was conﬁrmed in 6 animals. If intestinal schistosomiasis is to be
controlled within this setting, a long-term disease management plan is required which should combine active case-detection
with an insistent treatment regime with praziquantel for these chimpanzees, exploring perhaps the performance of even
higher dosing.
Key words: Schistosoma mansoni, Pan troglodytes, morbidity, ultrasonography, DNA barcoding.
INTRODUCTION
For the past 15 years, Ngamba Island Chimpanzee
Sanctuary (NICS) has been home to up to 44 wild-
borne, semi-captive chimpanzees (Pan troglodytes).
These animals were either rescued or conﬁscated by
operations of the Uganda Wildlife Authority (UWA)
or have been internationally transferred across the
pan-African Sanctuary Alliance (PASA) network
(Stothard et al. 2012). Despite being an attractive
and convenient forested setting with natural aquatic
boundaries, Ngamba Island is set within a sector of
Lake Victoria where intestinal schistosomiasis is
hyper-endemic and the animals are now considered
at-risk of this human disease (Standley et al. 2009;
Clements et al. 2010; Standley et al. 2010). Beginning
most likely as an anthropozoonosis, intestinal schis-
tosomiasis is now a nascent zoonosis as a shifting
balance between chimpanzee- and human-snail
transmission as local cycles play out (Stothard et al.
2012). Evidence to this end was gathered by
genotyping schistosomes collected from local people,
chimpanzees and snails byDNAbarcoding where the
sequence identity and diversity within the mitochon-
drial cytochome oxidase subunit I gene is compared
(Standley et al. 2011).
This changing appraisal ﬁrst began after malaco-
logical surveys on Ngamba revealed the presence of
infected intermediate snail hosts, Biomphalaria choa-
nomphala, which were found shedding Schistosoma
mansoni cercariae (Standley and Stothard, 2010;
Standley et al. 2010). Subsequently, this species of
snail could be found along almost the entirety of the
island’s shoreline where the chimpanzees were free to
roam (Standley et al. 2012b). Indeed, it was later
documented that just over 90% of examined chim-
panzees have antibodies against schistosome soluble
egg antigen (SEA) and active excretion of viable
schistosome eggs was conﬁrmed in several animals
(Standley et al. 2011). In an attempt to abate the
disease, annual blanket-treatment with praziquantel
(PZQ) at 40mg/kg dosing within animals’ food has
taken place since in early 2009 but is known not be
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optimal because it is diﬃcult to supervise directly the
intake of food and medications by each animal. As a
consequence perhaps, certain animals can be consist-
ently found to remain egg-patent, suggestive of either
poor administration and (or) performance of treatment,
active re-infection or even a combination of both.
Morbidity attributable to intestinal schistosomia-
sis, at least in man, is typically a chronic progression
associated with the accumulation of granulomata
around tissue-trapped eggs (King et al. 2003).
Among the many signs and symptoms, hepatomegaly
and liver ﬁbrosis are the most well known and can
vary, often on a case-by-case basis, from mild to
advanced, the latter being life-threatening owing to
an increased risk of abdominal haemorrhage (Balen
et al. 2006). In the context of animal welfare on
NICS, it is not known how developed, or potentially
serious, the morbidity associated with this disease
actually is. Gathering such information is therefore
fundamental in the development of a disease control
strategy and action plan for NICS where optimal
dosing methods with PZQ need to be explored.
This paper presents the results of 3 related surveys.
The ﬁrst was an attempt to shed light on the levels of
disease in key animals using portable ultrasonogra-
phy, when animals were anaesthetized during their
annual health check. The second hoped to reveal
more precisely the patterns of schistosome diversity
and transmission within chimpanzees by taking a
DNA barcoding approach. The third aimed to assess
the eﬃcacy of treatment as administered by oral
gavage with a stepped-up dosing of PZQ at 60mg/kg
which is recommended by theWHO in the treatment
of recalcitrant infections with S. mansoni (Stothard
et al. 2012).
MATERIALS AND METHODS
Study site and inclusion of earlier surveys
The study presented here was a follow-up of a
comprehensive parasitological survey of chimpanzees
and staﬀ that took place in February 2010 (Standley
et al. 2011). This paper presents the results of 3 sub-
sequent follow-up surveys with a combination of op-
portunistic and targeted animal sampling. The ﬁrst of
these follow-up surveys took place inNovember 2010
and focused on the collection and analysis of fecal
material and urine from a subset of chimpanzees, the
second was carried out in March 2011 involving a
more detailed clinical examination of animals under
general anaesthesia, alongside previously attempted
fecal andurine sample examinations, aswell as admin-
istration of stepped-up PZQ treatment at 60mg/kg
by oral gavage. The diagnostic procedures used
included ultrasonography for detection of putative
liver ﬁbrosis and rectal snip biopsy for detection of
calciﬁed schistosome eggs. The third survey was
conducted in June 2012 and was a parasitological
follow-up of the 8 animals treated by oral gavage with
standard fecal and urine sampling. Across the 3
surveys, a subset of 8 chimpanzees was examined in
greatest detail and the age and sex of the animals are
shown in Table 1.
Parasitological methods
Fecal and urine samples were collected opportunis-
tically by staﬀ members while the animals remained
in their overnight accommodation pens. Collected
urine specimens were tested on site with lateral ﬂow
dipsticks (Rapid Medical Diagnostics, Pretoria,
South Africa) that capture schistosome circulating
cathodic antigen (CCA) excreted in the animal’s
urine. Test results were read by eye as ‘negative’,
‘trace’ (considered borderline positive), ‘single posi-
tive’, ‘double positive’ and ‘triple positive’, based on
the strength of the test band relative to the control
measure. All reads were cross-checked by a second
independent observer.
Stool samples were examined by double Kato-
Katz thick smears and inspected at 100X magniﬁ-
cation (Katz et al. 1972). The numbers of eggs per
gramme (EPG) of feces were obtained to give a semi-
quantitive estimation of infection intensity. As a
qualitative alternative and format to collect eggs for
hatching of miracidia, a Pitchford funnel was used
to ﬁlter 5 g of freshly collected stool into a glass
Petri dish with 50ml of bottled mineral water. Post-
hatching, miracidia were individually collected in 3 μl
of water using a pipette and transferred to aWhatman
Indicating FTA® card (Whatman plc, Maidstone,
UK). Filter papers were then processed according to
manufacturer’s instructions to extract S. mansoni
DNA and PCR amplicons were sequenced, as per the
methodology in the following section. In contrast to
the survey in February 2010 as many miracidia as
possible from infected chimpanzees were collected, in
order to better determine genetic diversity within
each animal’s schistosome infection. When observed,
miracidia were also picked from infected animal stool
in the June 2012 follow-up.
Ultrasound examination and rectal snip biopsy
When secured within a holding cage, each animal was
anaesthetized, ﬁrst by intramuscular injection of
anaesthetic drugs using a combination of Ketamine
(5 mg/kg) and Meditomidine (0·05 mg/kg) and,
once relaxed, was transferred to the veterinary clinic,
weighed with a hanging sling, and then placed on the
examination table. The administered drugs for gen-
eral anaesthesia were suﬃcient in most cases through-
out examination procedures (i.e. within a 30-min
period). In only a few cases when examinations were
longer, a supplemental dose of the same combination,
at half the original dose, was administered
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intravenously under the supervision of NICS veter-
inarians.
For ultrasonography, the abdominal hair of each
animal was clipped to expose a 10×10 cm2 square of
skin on both the left and right ventral sides of the
lower ribs exposing the intercostal muscle area for
application of the ultrasound probe. The machine
used was a portable ultrasound machine with a
3·5 MHz convex probe/transducer (SSD-500, Aloka,
Tokyo, Japan), as has been used previously during
general disease surveillance and monitoring in
Uganda. The observed liver patterns were recorded
as a hard-copy print out, which was discussed, and
then scored according to standardized methods for
schistosomiasis liver pathology, the Niamey grading
system (King et al. 2003).
Rectal snips were performed using a plastic procto-
scope and biopsy spoon. Rectal snips, albeit not
directly quantiﬁable, are a qualitative measure for
detection of calciﬁed eggs that have become lodged in
the rectal mucosa, indicative of the progress of bowel
disease. Tissue snips (4–5mm) of rectal mucosa were
taken, ﬁxed in a 1% solution ofmalachite green in 50%
glycerol and ﬁrmly pressed between 2 glass slides and
then examined directly at 100Xmagniﬁcation (Khalil
et al. 1993).
Molecular methods and DNA barcoding
DNA was extracted from individual miracidia based
on published methods (Gower et al. 2007). A 396
base-pair fragment of the mitochondrial cytochrome
oxidase subunit 1, or cox1 DNA barcode, was then
ampliﬁed using the ASMIT 1 and ASMIT 2 primers
(Stothard et al. 2009), between 1 and 10 ng of
gDNA template and Ready-To-Go PCR beads (GE
Healthcare, Chalfont St Giles, UK) in a 25 μl total
reaction volume, and under standard thermal cycling
conditions (Stothard and Rollinson, 1997). Then 5 μl
of each PCR product was visualized on a 1% ethidium
bromide agarose gel, and ampliﬁed samples were
puriﬁed using a QIAQuick PCR Puriﬁcation Kit
(QIAGEN Ltd, Crawley, UK). Product concen-
tration was quantiﬁed on a Nanodrop ND-1000
Spectrophotometer (Nanodrop Technologies Inc.,
Willington, USA), and sequencing reactions were
performed on each puriﬁed PCR product using an
Applied Biosystems Big Dye Kit (version 1.1) and
run on an Applied Biosystems 3730 DNA Analyzer
(Applied Biosystems, Carlsbad, USA).
Sequences were compared to the existing dataset of
S. mansoni barcodes, from Lake Victoria and Lake
Albert (Standley et al. 2010). Novel barcodes were
sequentially numbered and submitted to GenBank
(http://www.ncbi.nlm.nih.gov/genbank). The unique
barcodes from the November 2010 survey were
combined into a TCS minimum-spanning step-
wise network (http://darwin.uvigo.es/software/tcs.
html). These were then added to the larger databaseT
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of ASMIT barcodes from earlier trips to Ngamba
Island, including miracidia from chimpanzee feces,
cercariae isolated from local snails, miracidia from
Ngamba Island staﬀ members and miracidia from
children on neighbouring Kimi Island. These data
were used to build a Neighbour-joining distance tree
of the overall Ngamba-area S. mansoni haplotype
diversity, using a maximum composite likelihood
model of nucleotide substitution and a gamma shape
parameter of 0·30. Model testing and tree-building
was done using MEGA 5 (Tamura et al. 2011).
Treatment with praziquantel
After the survey in November 2010, all the chimps
were treated in a semi-supervised manner with
40mg/kg of praziquantel tablets, orally administered
in their daily provided feed, porridge and fruits.
Earlier treatments had also been delivered in this
fashion, in February 2009 and February 2010. To
recordmore precisely and closely supervise treatment
of the 8 animals, crushed PZQ tablets (60mg/kg)
were suspended in 100ml of bottled water and
administered to each animal by gastric tube while
the animals were anaesthetized in the March 2011
survey. To assess the parasitological performance of
this dosing regime, the stool and urine of these
animals were re-examined in June 2012 using
diagnostic methods as described above.
Ethical considerations
Ethical clearance to survey and to take samples from
the chimpanzees was granted by the Uganda Wildlife
Authority and the Uganda National Council for
Science and Technology (UNCST). All stool and
urine samples were collected by keepers who were
known to the animals, thus causing a minimum of
disturbance to the animals’ daily routines. The chief
NICS veterinarian assisted and supervised all pro-
cedures undertaken on chimpanzees.
RESULTS
Parasitological surveys in November 2010
The November 2010 survey focused on collecting
fecal and urine samples from chimpanzees on
Ngamba Island with known prior schistosomiasis
infection, based on earlier surveys (Standley et al.
2011). Figure 1 shows collection sites for cercariae, as
well as the location maps of Ngamba and its
neighbouring island Kimi where further schistosome
sampling took place.
Urine samples were collected from 16 chimpanzees
(9 individuals were tested on multiple days), with 5
testing positive for infection upon circulating catho-
dic antigen (CCA) rapid lateral ﬂow tests. This
corresponds to a prevalence of 31·25% (95% conﬁ-
dence intervals (CIs)=11·0–58·7). A fecal sample was
Fig. 1. Map of Ngamba Island and schistosome collection sites. Kimi Island is separated from Ngamba Island by a
strait of approximately 1 kilometer, and several NICS staﬀ commute daily between islands. Both islands have been
visited as part of on-going Uganda-wide schistosomiasis monitoring and control activities since 2008.
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collected from 12 animals and S. mansoni eggs were
observed in Kato-Katz double thick smears in 4 of
these samples, indicating a prevalence of 33·3% (95%
CIs=9·9–65·1). All infections were of ‘light’ egg
intensity (i.e. <100 epg). Of the stool egg-positive
samples, 3 were from chimpanzees that had been
found to be positive in earlier surveys (Sunday,
Kidogo and Rutoto). The fourth egg-positive chim-
panzee, named Surprise, had not been previously
surveyed. One animal, Kalema, which beforehand
was egg-positive, was now found both egg and CCA-
negative.
Schistosome eggs from the fecal samples were
isolated and concentrated, from stool samples of 4
chimpanzees, all of whom had tested as egg-positive
in both this and in earlier surveys: Kidogo, Rutoto,
Sunday and Surprise. Approximately 20 miracidia
were gathered from each of the chimpanzee’s stool
samples and placed on Whatman FTA Indicating®
cards for later DNA analysis.
Ultrasound examination and rectal snip biopsy in
March 2011
Targeted fecal sampling obtained specimens from 8
animals, including the 4 egg-positive individuals
from November 2010. These 4 animals had again
received semi-supervised praziquantel treatment in
their food. Kidogo, Sunday and Rutoto again pres-
ented with S. mansoni eggs in their stool; these 3
chimpanzees were also strongly CCA-positive.
Surprise was egg-negative, although strongly CCA-
positive. Of the 4 other chimpanzees surveyed at this
time (which included Kalema, a previously infected
chimpanzee), only 1 female (Connie) was egg-
positive, though she had a negative CCA test (Fig. 2).
In total, 8 animals were available for examination
by portable ultrasonography and using rectal snip
biopsy. Although 2 of the chimpanzees had normal
liver patterns, analysis of the ultrasound images
revealed a spectrum of liver disease: 2 animals had
mild ﬁbrosis, 3 animals had moderate ﬁbrosis and 1
animal presented with severe ﬁbrosis. These patterns
are indicative of active infection progressing towards
chronic morbidity. In terms of rectal snip biopsy,
eggs of S. mansoni were recovered from 5 animals,
including an animal that was previously considered
infection-negative by stool and urine examinations.
Table 1 is a summary of these ﬁndings for these
8 animals examined.
DNA barcoding schistosome diversity
Schistosoma mansoni sequences from earlier surveys
to the Ngamba Island area were included in the
overall analysis of genetic diversity in an attempt to
match parasite to deﬁnitive hosts. This included
DNA barcodes from schistosomes retrieved from
NICS staﬀ as well as from infected children on the
neighbouring Kimi Island. In addition, DNA
barcodes from schistosome cercariae harvested from
infected snails that were collected from the shoreline
of both islands were available for comparisons (see
Fig. 1). These surveys included an initial snail
collection in March 2008 (Standley et al. 2009,
2010), as well as the DNA barcodes obtained from a
parasitological survey of animals in February 2010.
Overall, after the November 2010 survey, 57 DNA
barcodes (cox1 sequences of the ASMIT fragment)
were successfully produced from miracidia hatched
from the 4 chimpanzee stools. Of these, 16 sequences
were from Sunday, 18 sequences were from Rutoto,
13 sequences were from Surprise and 10 sequences
were from Kidogo. In total, these DNA barcodes
corresponded to 27 unique types, i.e. 16 of these
matched already identiﬁedDNA barcodes in Uganda
while the remaining 11 were novel barcodes and had
not been encountered previously. These were
labelled H154-H164 and submitted to GenBank
(Accession numbers JF508491-JF508501). Of the
individual chimps, the distribution of DNAbarcodes
by chimpanzee was complex and individual-speciﬁc;
10 diﬀerent DNA barcodes were identiﬁed within
Rutoto, 8 within Sunday, 9 within Surprise and 7
within Kidogo. Notably, certain DNA barcodes had
been previously encountered within Sunday and 2 of
these (H1 and H16) were recovered in this survey.
A summary of the DNA barcodes by chimpanzee is
shown in Table 2.
Fig. 2. Examples of chimpanzee liver patterns, as shown by ultrasound. Image A shows mild ﬁbrosis, indicative of a ‘B’
pattern; Image B shows the beginning of pipe-stem formation, indicative of a ‘C’ pattern of pathology and Image C
shows pipe-stem formation as well as occluding ﬁbrosis, indicative of ‘D’ level pathology.
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The novel barcodes diﬀerentiated from H1,
the most common barcode, by a maximum of 8 base
changes (corresponding to a 1·2% diﬀerence) and a
minimum of 1 base change (Table 3). Barcode H1
was encountered in Sunday, Surprise and Rutoto but
appeared absent in Kidogo. It is of particular note
that no DNA barcode obtained from Kidogo was
encountered in any of the other 3 animals. A total of
6 DNA barcodes (H1, H2, H15, H16 and H36) were
common to one or more animals while the remaining
21 DNA barcodes were animal-speciﬁc.
The relationship between the sequence variation
between DNA barcodes found in these 4 chimpan-
zees was examined using a step-wise minimum span-
ning TCS network (Fig. 3). The network revealed
H1, the most abundant barcode, as one of the central
nodes, with the majority of the other barcodes related
by only one or two step-wise base changes. The only
lineage which appeared to be more divergent was
H79; this was supported by the Neighbour-joining
tree (with branch support given by 1000 bootstrap
replicates) which indicated low diﬀerentiation across
most of the Ngamba-Kimi region barcodes, apart
from the group containing H79 which had strongly
supported divergence (Fig. 4). Parasites with DNA
barcodes representing this group have been
encountered in both humans and chimpanzees as
miracidia and in snails as cercariae; H14 was actually
found in all 3 hosts at various stages of 2010,
indicating spatial and temporal sympatry. Other
sequences, namely H1 and H15, were also found in
snails, humans and chimpanzees, sometimes during
the same survey.
Performance of PZQ treatment at 60 mg/kg
In an attempt to better administer stepped-up dosing
of PZQ at 60mg/kg of bodyweight, oral gavage was
used and allowed direct administration of this drug
to all 8 chimpanzees, without incident, in the March
2011 survey. The animals were monitored post-
anaesthesia for recovery. Abnormal watery diarrhoea,
although not uncommon following recovery from
anaesthesia, was observed in Rutoto, and post-
recovery vomiting of a small amount of treatment
by Kalema was observed but not considered an
ineﬀective treatment administration. In June 2012
the stool and urine from these animals were examined
using Kato-Katz and urine CCA dipsticks. Only 1
animal, Kalema, appeared to be free from infection,
see Table 1. The egg counts of all infected animals
were less than 100 epg. Miracidia, harvested from
Sunday and Surprise, were subjected to DNA bar-
coding with the resultant genotypes reported in
Table 2. Haplotype 16 has been continuously found
within Sunday upon all parasitological samplings.
However, 2 new DNA barcodes, H174 and H175,
were encountered from Sunday and have also
been submitted to GenBank (Accession numbers
JX845583 and JX845584).
DISCUSSION
The results of these surveys showed that not only are
chimpanzees capable of being infected with a
diversity of schistosomes comparable to that of
human infections, they also appear to suﬀer from
similar clinical manifestations as witnessed in the
classiﬁcation of liver ﬁbrosis along the Niamey image
classiﬁcation key. As far as we are aware, these are the
ﬁrst fully documented cases of progressive disease
attributable to intestinal schistosomiasis within a
colony of chimpanzees, albeit set within this semi-
natural environment of the NICS. The results from
the ultrasound, although a ﬁrst snapshot, are indica-
tive of varying stages of the chronic disease pro-
gression typical of active S. mansoni infection(s).
Despite a few individuals appearing to have some
inconsistencies in diagnosis between methods or time
points, Table 1 clearly aﬃrms that the disease is
engrained in several of these animals, even more so
when diagnostic results from the June 2012 are
considered. The most severely aﬄicted individual,
Rutoto had a liver ﬁbrosis pattern consistent with
advanced morbidity despite being the youngest
Table 2. List and identity of Schistosoma mansoni
DNA barcodes found in 4 infected chimpanzees in
November 2010 and then in June 2012
Chimpanzee
(number of
sequences)
DNA
barcode
(occurrence)
Chimpanzee
(number of
sequences)
DNA
barcode
(occurrence)
Sunday
(16 & 7)
H1 (8 & 2)
Surprise
(13 & 1)
H2 (2) H1 (3)
H10 (1 & 1) H15 (1)
H14 (1) H46 (1)
H16 (1 & 1) H79 (3)
H42 (1) H127 (1)
H79 (1) H158* (1)
H124 (1) H159* (1)
H154* (1) H160* (1)
H174* (1) H161* (1)
H175* (1) H162* (1)
Rutoto (18)
H1 (4)
Kidogo (10)
H15 (2)
H16 (3) H36 (2)
H23 (2) H138 (1)
H36 (2) H163* (1)
H54 (1) H164* (2)
H103 (1) H2 (1)
H155* (1) H10 (2)
H156* (1) H17 (1)
H157* (1)
* Novel DNA barcodes ﬁrst encountered in these surveys;
underlining indicates DNA barcodes that had previously
been found in that individual during earlier surveys.
Barcodes in plain text were found only in November
2010; barcodes in italics were found only in June 2012 and
barcodes in bold were found in both surveys.
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animal examined. This would also point towards this
animal having hepato-portal hypertension and likely
abdominal varices, the latter are especially diﬃcult to
detect without recourse to more advanced imaging
techniques.
The detection of advanced morbidity is a crucial
ﬁnding, since to the authors’ knowledge, the signiﬁ-
cance of naturally-acquired infections in a colony of
chimpanzees has never been documented. Within the
setting of experimental schistosomiasis, progressive
liver disease is known and can become severe in
chimpanzees (Eberl et al. 2001). In this sanctuary
setting, however, clearly recording the level of disease
in NICS animals is a fundamental starting point in
developing a disease management strategy for their
welfare. With the ﬁrm intention of averting further
morbidity in all animals, a key assumption, of course,
is that future PZQ treatment(s) will give an eﬀective
worm kill. Presently the performance of this drug is
becoming more contentious; further evidence of
engrained infection within the colony was that urine
samples from a further 25 NICS chimpanzees were
spot-checked in the June 2012 by CCA dipsticks
survey ﬁnding 15 to be positive.
Prior to the March 2011 treatment, the poorer
performance of PZQ is most likely to be due to a
suboptimal dosing within its previously semi-super-
visedmanner when administered in food. In search of
better administrationmethods, to explore this further
it would seem that administration of PZQ (in
suspension) via a gastric tube would be the preferred
option but can only be attempted under general
anaesthesia. Foremost is that this method of admin-
istration is directly supervised and that the mass of
the animal is accurately measured, immediately
before treatment, so precise bodyweight dosing can
be given. In terms of long-term parasitological cure,
there is little to be optimistic about the results of the
June 2012 survey presented in Table 1. If more
sensitive diagnostics tools such as real-time PCR
detection of schistosome DNA in stool (Standley
et al. 2011) had been used, infection may have also
been observed in Kalema. A future of drawback of
this mode of administration of treatment under
anaesthesia is that it can only be undertaken during
the annual health check but higher dosings of PZQ
could be easily explored in the search of increasing
performance. Given that nearly all animals were
found excreting eggs in the June 2012 follow-up,
conducting an exploratory trial using PZQ at 80mg/
kg, with a non-invasive parasitological follow-up at
1 month, would be immediately sensible before
recourse to alternative drugs such as oxamniquine
(which is presently very diﬃcult to obtain).
Diversity of schistosome infections
The DNA barcoding has revealed that the genetic
diversity of the schistosomes in the 4 chimpanzeesT
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included in this survey was high, especially given the
relatively low egg counts and few samples that were
able to be sequenced. This result is, however,
comparable to the situation as found in human
communities, particularly in highly endemic areas
for the disease (Balen et al. 2006; Standley et al.
2010). What is perhaps most surprising, is that
infection has persisted at such high diversities despite
the frequent treatment with PZQ that has been
administered to these animals since the ﬁrst survey in
2009. There are 3 possible explanations for the
maintenance of within-host parasite genetic diversity
in the face of PZQ treatment. First is that treatment
was successful, but re-exposure to genetically diverse
cercariae, emerging from snails around the shoreline
of the island, has resulted in the re-establishment of a
highly diverse infection. Second, but related to this,
is that exposure could be on-going and so although
treatment was successful, immature worms of diﬀer-
ent DNA barcodes were still developing and helping
to contribute to the observed diversity upon post-
treatment follow-up. To clarify this, a longitudinal
survey of egg diversity, closely centered around the
weeks before and after treatment with PZQ, might be
able to distinguish between these two hypotheses,
alongside intensive malacological surveys aimed to
identify snails shedding cercariae. Third, PZQ
treatment(s) may have failed and allowed the diver-
sity of the original infection to remain relatively
undisturbed. Evidence to this end was the common
occurrence of DNA barcode H1 and especially H16
in Sunday between all inspection time-points. In
future more advanced DNA proﬁling with other
molecular markers, such as microsatellites, might
hope to investigate these schistosome subtypes with
greater discrimination and better assess the impact of
PZQ treatment (Steinauer et al. 2010; Criscione and
Blouin, 2005).
Another important ﬁnding, which was initially
remarked upon after the February 2010 survey
(Standley et al. 2011) and can be elaborated on with
the additional samples provided here, was the co-
occurrence and observation of phylogenetic overlap
between DNA barcodes found in cercariae from local
snails and eggs/hatchedmiracidia from humans. This
suggests conjoined transmission cycles through both
humans and chimpanzees, rather than separate ones
for several DNA barcodes (H1, H2, H10, H14, H15,
H16, H17, H23 and H26), which might result in
diverging groups of parasites found between the
species. Similarly, there was no geographical separ-
ation of DNAbarcodes as obtained between retrieved
schistosomes from Kimi and Ngamba Islands; this is
consistent with earlier reports of high levels of genetic
mixing and low geographically deﬁned population
structure among S. mansoni in Lake Victoria as a
whole (Standley et al. 2010).
Signiﬁcant sequence divergence was exhibited by
the presence of a well-supported group (see Fig. 4
inclusive of the group containing H14 and H156
barcodes), found in the form of cercariae in snails as
well as miracidia in both chimpanzees and human
terminal hosts. This group contains some abundant
DNA barcodes as well as rarely observed ones, and
sequences from this group have been found through-
out Lake Victoria (Stothard et al. 2009; Standley
et al. 2010). It has been previously hypothesized that
this corresponds to a separate ‘lineage’ of S. mansoni,
Fig. 3. Minimum-spanning step-wise network of DNA barcodes of Schistosoma mansoni recovered from chimpanzees.
The total abundance of each DNA barcode is indicated by the number in parenthesis after the DNA barcode number.
The proportion of each DNA barcode recovered from each of the four infected chimpanzees is given by the colour of the
pie slice, as per the key.
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Fig. 4. Neighbour-joining distance-based tree of all Ngamba Island and Kimi Island DNA barcodes of Schistosoma
mansoni. Schistosome sequences were collected from miracidia (from chimpanzees and human staﬀ members on
Ngamba Island, and school-aged children on Kimi Island) and cercariae from shedding Biomphalaria on both islands,
between 2008 and 2010. The time of collection and host is given by the shape and colour of the polygon next to the
DNA barcode, as per the key.
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as deﬁned by Morgan and colleagues (Morgan et al.
2005) and corroborated by Stothard et al. (2009) and
Webster et al. (2012), but without a re-analysis of a
diﬀerent fragment of the cox1 gene (which would
require additional sampling), this cannot be compre-
hensively determined. If it is indeed a separate
lineage, then it is worth noting that certain individ-
uals, for example Sunday, Surprise and Rutoto
(intriguingly not Kidogo) appear to be infected
with multiple lineages of S. mansoni. If this is the
case, then it oﬀers up the question of how such
divergence can be maintained in the face of geo-
graphical as well as intra-host mixing; such questions
warrant further investigation especially in the light of
DNA barcodes H154-H164, H174 and H175 which
have only been encountered, as yet, within chimpan-
zees. This would suggest that an animal’s exposure
and infection ‘window’ to schistosome cercariae,
albeit inferred by subsequent analysis of eggs, is
highly variable even on this small island setting. This
was clearly evidenced in that no one DNA barcode
type was common to all animals which may have
some bearing on the diversity and evolution of host
morbidity. Taken as a whole, if further disease
progression is to be averted, a long-term disease
management strategy is required which, for selected
animals, should combine more active case-detection,
with parasite genotyping, alongside a closely moni-
tored morbidity-reduction action plan.
In conclusion, intestinal schistosomiasis in NICS
is a signiﬁcant present and future threat to the welfare
of these chimpanzees. The local epidemiology of the
disease appears to be a shifting balance between
anthropozoonotic and zoonotic cycles which may
have some bearing on the progression of individual
host-morbidity for which overt disease has been
clearly documented, i.e. liver ﬁbrosis. Indeed, the
schistosome population within each of the examined
chimpanzees has a complex structure of parasite
DNA barcodes with either human-like or chimp-like
signatures. Whilst better administration of PZQ can
be achieved by delivery of drug by gastric tube, such
procedures are restricted to the annual health check
cycle on NICS and do not appear to eliminate infec-
tions upon a 15-month parasitological follow-up after
a prior and closely supervised 60mg/kg treatment.
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